OncLive Welcomes Medical University of South Carolina's Hollings Cancer Center to Strategic Alliance Partnership Program

PLAINSBORO, N.J. —(Feb 24, 2015) – OncLive^®today welcomes the Medical University of South Carolina’s Hollings Cancer Center as a partner in promoting the latest advances in cancer research, treatment and care through OncLive’s Strategic Alliance Partnership program.

In the new partnership, OncLive’s editorial and marketing teams will publicize important cancer-related news from Hollings Cancer Center, the largest academic cancer center in South Carolina. With over 200 experts in treatment, research, education, prevention and outreach, Hollings Cancer Center is leading the way in improving cancer care.

Hollings Cancer Center is the only cancer center in South Carolina that has earned National Cancer Institute designation, recognition of the center’s exemplary science and capacity to combine a variety of research approaches to attack the cancer problem.

Mike J. Hennessy Jr., senior vice president, oncology & specialty pharmacy, which includes OncLive,said, “We are pleased to partner with Hollings Cancer Center to spread the word about new developments in cancer research and care, from the Center’s approach to patient care to its research approaches that look at cancer from every angle. OncLive believes that sharing these stories will inspire the work of others.”

Anthony J. Alberg, Ph.D., interim director of Hollings Cancer Center, said, “We are devoted to decreasing South Carolina’s cancer burden by providing the most advanced cancer care to our current patients while investigating promising routes to better treatments in the future, with research that stretches from the laboratory to the clinic and to the community. We are pleased to partner with OncLive to share information that could make a difference for patients and healthcare providers well beyond our state’s borders.”

Hollings Cancer Center joins more than 30 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive.

Hennessy added, “The Strategic Alliance Partnership program serves everyone committed to fighting cancer. When we work together and share our knowledge broadly, we are better armed to improve our efforts to overcome this devastating disease.”

About OncLive^®

OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. OncLive offers oncology professionals resources and information they need to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, NJ. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE^TM magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit www.OncLive.com.

About Hollings Cancer Center

Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer program in South Carolina. In addition to the full range of clinical services, the cancer center has more than $43 million in cancer research funding and more than 200 clinical trials open to patients. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques with multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped to the full range of cancer care. For more information, please visit www.hcc.musc.edu.

###

Media Contacts:

For Hollings:Allison Leggett, 843-792-0376,leggett@musc.edu

For OncLive: Becky Taylor, 609.240.6886, becky@btaylorpa.com